Blood Review Series – Emerging Immunotherapies for Hematologic Diseases
2,105 views · Published 14 June 2018 · 6:58 · Indexed 12 November 2026
Channel: American Society of Hematology · 2018 · Nonprofits & Activism
Catherine M. Bollard, MBChB, MD, and Leslie S. Kean, MD, PhD, share highlights of this review series which examines chimeric antigen receptor T cells and their toxicities, vaccine therapies, and cellular therapies for graft-versus-host disease. Read articles in this review series: http://www.bloodjournal.org/page/review-series/ei
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding